Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910323 · ClinicalTrials.gov registry record
The Will Erwin Headache Research Center - Cluster Headache Study
A clinical trial of Trigeminal Neuralgia and Cluster Headache, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT02910323: Recruiting study of Trigeminal Neuralgia and Cluster Headache, sponsored by The University of Texas Health Science Center, Houston.
NCT02910323 is a study of Trigeminal Neuralgia and Cluster Headache that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,500 participants, below the 5,603-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02910323, a study of Trigeminal Neuralgia and Cluster Headache, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.
Conditions Studied
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2016-07-12 |
| Est. Completion | 2035-12 |
What NCT02910323 shows while recruiting
NCT02910323 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, below the 5,603-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (73% lower).
The record links to 6 conditions, with Trigeminal Neuralgia appearing as the primary indexed condition, and to 0 interventions.
NCT02910323 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02910323 about?
NCT02910323 is a clinical study titled "The Will Erwin Headache Research Center - Cluster Headache Study". The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.
What is the current status of trial NCT02910323?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2016-07-12. Estimated completion is 2035-12.
What conditions does trial NCT02910323 study?
This clinical trial studies the following conditions: Trigeminal Neuralgia, Cluster Headache, Paroxysmal Hemicrania, Cluster Headaches and Other Trigeminal Autonomic Cephalgias, SUNCT.
Who is sponsoring clinical trial NCT02910323?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02910323 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trigeminal Neuralgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02910323's enrollment target sits among peer trials
1,500 2nd of 9 the highest of 9 other Trigeminal Neuralgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trigeminal Neuralgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OnabotulinumtoxinA for Trigeminal Neuralgia
RECRUITING · Phase 4
-
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
RECRUITING
-
Trigeminal Evoked Responses to Improve Rhizotomy
RECRUITING · Early Phase 1
-
Trigeminal Neuralgia Electrophysiology
RECRUITING
-
RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
ACTIVE NOT RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI